World Allergy Diagnostics Market to Keep on Growing through 2022, States Stratistics MRC in Its In-demand Report Available at MarketPublishers.com01 Dec 2016 • by Natalie Aster
LONDON – As of 2015, the world’s market for allergy diagnostics stood at around USD 2.7 billion. During 2016-2022, driven by growing expenditures on healthcare, increasing environmental pollution, ageing population and certain financial hardships associated with allergic diseases, this market is expected to reach almost USD 6.3 billion, posting a CAGR of more than 12%. Nevertheless, further growth in the allergy diagnostics market is set to be significantly restrained by severe regulations and high capital investments.
The global allergy diagnostics market is dominated by the reagents kit segment, which commands the mammoth share of the whole market. On the back of the rising number of allergy incidence, the reagents kit segment is predicted to see remarkable growth in the offing, registering the fastest CAGR.
Regionally, North America is an absolute leader in the global market for allergy diagnostics owing to the rising number of aged people and increasing pollution coupled with expanding urbanization in the region. However, the APAC allergy diagnostics market is anticipated to register the highest CAGR due to huge untapped opportunities in the region.
One of the latest insightful research reports titled “Allergy Diagnostics - Global Market Outlook (2016-2022)” worked out by Stratistics Market Research Consulting (MRC) provides a deep analysis of the world’s allergy diagnostics marketplace on the global, regional and country scales, uncovers info on the market shares and market dynamics (including growth drivers, constraints, challenges, possible investments opportunities). This all-encompassing publication is a great source of strategic recommendations for new entrants and established market players. Moreover, the study touches upon supply chain structure and top trends, highlights the latest technological advancements, examines the competitive scenario, offers detailed profiles of the key market players and contains future granular forecasts till 2022.
Companies mentioned in the report: Siemens AG, HYCOR Biomedical, Omega Diagnostics Group PLC, Danaher Corporation, HOB Biotech Group, Stallergenes Greer, BioMerieux, Thermo Fisher Scientific, Lincoln Diagnostics, Hitachi Chemical Diagnostics, Allercheck, SmartPractice Denmark ApS, Bio-Diagnostics, ERBA Mannheim Group, Terumo Medical Corporation and Diagenics.
Other research studies by Stratistics Market Research Consulting are available in its catalogue.